Performance Evaluation of a Novel Artificial Intelligence-Assisted Digital Microscopy System for the Routine Analysis of Bone Marrow Aspirates

被引:2
作者
Bagg, Adam [1 ]
Raess, Philipp W. [2 ]
Rund, Deborah [3 ]
Bhattacharyya, Siddharth [1 ]
Wiszniewska, Joanna [2 ]
Horowitz, Alon [3 ]
Jengehino, Darrin [1 ]
Fan, Guang [2 ]
Huynh, Michelle [1 ]
Sanogo, Abdoulaye [1 ]
Avivi, Irit [3 ,4 ]
Katz, Ben-Zion [3 ,4 ,5 ]
机构
[1] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA
[2] Oregon Hlth & Sci Univ, Dept Pathol & Lab Med, Portland, OR USA
[3] Tel Aviv Sourasky Med Ctr, Div Hematol, Tel Aviv, Israel
[4] Tel Aviv Univ, Fac Med & Hlth Sci, Tel Aviv, Israel
[5] Tel Aviv Sourasky Med Ctr, Div Clin Labs, Tel Aviv, Israel
关键词
differential count; digital morphology; hematological malignancies; leukemia; multiple myeloma; MYELOID-LEUKEMIA; ICSH GUIDELINES; DIAGNOSIS; STANDARDIZATION; CLASSIFICATION;
D O I
10.1016/j.modpat.2024.100542
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Bone marrow aspiration (BMA) smear analysis is essential for diagnosis, treatment, and monitoring of a variety of benign and neoplastic hematological conditions. Currently, this analysis is performed by manual microscopy. We conducted a multicenter study to validate a computational microscopy approach with an artificial intelligence-driven decision support system. A total of 795 BMA specimens (615 Romanowsky-stained and 180 Prussian blue-stained) from patients with neoplastic and other clinical conditions were analyzed, comparing the performance of the Scopio Labs X100 Full Field BMA system (test method) with manual microscopy (reference method). The system provided an average of 1,385 +/- 536 (range, 0-3,131) cells per specimen for analysis. An average of 39.98 +/- 19.64 fields of view (range, 0-140) per specimen were selected by the system for analysis, of them 87% +/- 21% (range, 0%-10 0%) were accepted by the qualified operators. These regions were included in an average of 17.62 +/- 7.24 regions of interest (range, 1-50) per specimen. The efficiency, sensitivity, and specificity for primary and secondary marrow aspirate characteristics (maturation, morphology, and count assessment), as well as overall interuser agreement, were evaluated. The test method showed a high correlation with the reference method for comprehensive BMA evaluation, both on Romanowsky- (90.85% efficiency, 81.61% sensitivity, and 92.88% specificity) and Prussian blue-stained samples (90.0% efficiency, 81.94% sensitivity, and 93.38% specificity). The overall agreement between the test and reference methods for BMA assessment was 91.1%. For repeatability and reproducibility, all standard deviations and coefficients of variation values were below the predefined acceptance criteria both for discrete measurements (coefficient of variation below 20%) and differential measurements (SD below 5%). The high degree of correlation between the digital decision support system and manual microscopy demonstrates the potential of this system to provide a high-quality, accurate digital BMA analysis, expediting expert review and diagnosis of BMA specimens, with practical applications including remote BMA evaluation and possibly new opportunities for the research of normal and neoplastic hematopoiesis. (c) 2024 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology. This is an open access article under the CC BY license (http://creativecommons.org/ licenses/by/4.0/).
引用
收藏
页数:10
相关论文
共 25 条
  • [1] Initial Diagnostic Workup of Acute Leukemia Guideline From the College of American Pathologists and the American Society of Hematology
    Arber, Daniel A.
    Borowitz, Michael J.
    Cessna, Melissa
    Etzell, Joan
    Foucar, Kathryn
    Hasserjian, Robert P.
    Rizzo, J. Douglas
    Theil, Karl
    Wang, Sa A.
    Smith, Anthony T.
    Rumble, R. Bryan
    Thomas, Nicole E.
    Vardiman, James W.
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2017, 141 (10) : 1342 - 1393
  • [2] Limitations of poor bone marrow aspirations (for an accurate diagnosis) despite the multimodal analytical era: A longitudinal retrospective study
    Astle, John M.
    Xu, Mina L.
    Friedman, Tamir
    Brown, Elliott
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (10) : E600 - E602
  • [3] Is the Association of "Cup-like" Nuclei With Mutation of the NPM1 Gene in Acute Myeloid Leukemia Clinically Useful?
    Bennett, John M.
    Pryor, Jennifer
    Laughlin, Todd S.
    Rothberg, Paul G.
    Burack, W. Richard
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 134 (04) : 648 - 652
  • [4] Bermejo-Pelaez D, 2022, medRxiv
  • [5] Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO
  • [6] 2-F
  • [7] Clinical and Laboratory Standards Institute (CLSI), 2013, CLSI document EP9-A3: Method comparison and bias estimation using patient samples
  • [8] Clinical Laboratory Standards Institute (CLSI), 2007, H20A2 CLSI
  • [9] Chronic Myeloid Leukemia, Version 2.2021
    Deininger, Michael W.
    Shah, Neil P.
    Altman, Jessica K.
    Berman, Ellin
    Bhatia, Ravi
    Bhatnagar, Bhavana
    DeAngelo, Daniel J.
    Gotlib, Jason
    Hobbs, Gabriela
    Maness, Lori
    Mead, Monica
    Metheny, Leland
    Mohan, Sanjay
    Moore, Joseph O.
    Naqvi, Kiran
    Oehler, Vivian
    Pallera, Arnel M.
    Patnaik, Mrinal
    Pratz, Keith
    Pusic, Iskra
    Rose, Michal G.
    Smith, B. Douglas
    Snyder, David S.
    Sweet, Kendra L.
    Talpaz, Moshe
    Thompson, James
    Yang, David T.
    Gregory, Kristina M.
    Sundar, Hema
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (10): : 1385 - 1415
  • [10] Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes
    Della Porta, M. G.
    Travaglino, E.
    Boveri, E.
    Ponzoni, M.
    Malcovati, L.
    Papaemmanuil, E.
    Rigolin, G. M.
    Pascutto, C.
    Croci, G.
    Gianelli, U.
    Milani, R.
    Ambaglio, I.
    Elena, C.
    Ubezio, M.
    Da Via, M. C.
    Bono, E.
    Pietra, D.
    Quaglia, F.
    Bastia, R.
    Ferretti, V.
    Cuneo, A.
    Morra, E.
    Campbell, P. J.
    Orazi, A.
    Invernizzi, R.
    Cazzola, M.
    Network, R. E. L. Clinical
    [J]. LEUKEMIA, 2015, 29 (01) : 66 - 75